These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 24504326)

  • 21. Functional effects of disease-associated variants reveal that the S1-M1 linker of the NMDA receptor critically controls channel opening.
    Xie L; McDaniel MJ; Perszyk RE; Kim S; Cappuccio G; Shapiro KA; Muñoz-Cabello B; Sanchez-Lara PA; Grand K; Zhang J; Nocilla KA; Sheikh R; Armengol L; Romano R; Pierson TM; Yuan H; Myers SJ; Traynelis SF
    Cell Mol Life Sci; 2023 Mar; 80(4):110. PubMed ID: 37000222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneous clinical and functional features of GRIN2D-related developmental and epileptic encephalopathy.
    XiangWei W; Kannan V; Xu Y; Kosobucki GJ; Schulien AJ; Kusumoto H; Moufawad El Achkar C; Bhattacharya S; Lesca G; Nguyen S; Helbig KL; Cuisset JM; Fenger CD; Marjanovic D; Schuler E; Wu Y; Bao X; Zhang Y; Dirkx N; Schoonjans AS; Syrbe S; Myers SJ; Poduri A; Aizenman E; Traynelis SF; Lemke JR; Yuan H; Jiang Y
    Brain; 2019 Oct; 142(10):3009-3027. PubMed ID: 31504254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early onset epileptic encephalopathy caused by de novo SCN8A mutations.
    Ohba C; Kato M; Takahashi S; Lerman-Sagie T; Lev D; Terashima H; Kubota M; Kawawaki H; Matsufuji M; Kojima Y; Tateno A; Goldberg-Stern H; Straussberg R; Marom D; Leshinsky-Silver E; Nakashima M; Nishiyama K; Tsurusaki Y; Miyake N; Tanaka F; Matsumoto N; Saitsu H
    Epilepsia; 2014 Jul; 55(7):994-1000. PubMed ID: 24888894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HCN1 mutation spectrum: from neonatal epileptic encephalopathy to benign generalized epilepsy and beyond.
    Marini C; Porro A; Rastetter A; Dalle C; Rivolta I; Bauer D; Oegema R; Nava C; Parrini E; Mei D; Mercer C; Dhamija R; Chambers C; Coubes C; Thévenon J; Kuentz P; Julia S; Pasquier L; Dubourg C; Carré W; Rosati A; Melani F; Pisano T; Giardino M; Innes AM; Alembik Y; Scheidecker S; Santos M; Figueiroa S; Garrido C; Fusco C; Frattini D; Spagnoli C; Binda A; Granata T; Ragona F; Freri E; Franceschetti S; Canafoglia L; Castellotti B; Gellera C; Milanesi R; Mancardi MM; Clark DR; Kok F; Helbig KL; Ichikawa S; Sadler L; Neupauerová J; Laššuthova P; Šterbová K; Laridon A; Brilstra E; Koeleman B; Lemke JR; Zara F; Striano P; Soblet J; Smits G; Deconinck N; Barbuti A; DiFrancesco D; LeGuern E; Guerrini R; Santoro B; Hamacher K; Thiel G; Moroni A; DiFrancesco JC; Depienne C
    Brain; 2018 Nov; 141(11):3160-3178. PubMed ID: 30351409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. De novo mutations in HCN1 cause early infantile epileptic encephalopathy.
    Nava C; Dalle C; Rastetter A; Striano P; de Kovel CG; Nabbout R; Cancès C; Ville D; Brilstra EH; Gobbi G; Raffo E; Bouteiller D; Marie Y; Trouillard O; Robbiano A; Keren B; Agher D; Roze E; Lesage S; Nicolas A; Brice A; Baulac M; Vogt C; El Hajj N; Schneider E; Suls A; Weckhuysen S; Gormley P; Lehesjoki AE; De Jonghe P; Helbig I; Baulac S; Zara F; Koeleman BP; ; Haaf T; LeGuern E; Depienne C
    Nat Genet; 2014 Jun; 46(6):640-5. PubMed ID: 24747641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GRIN2B mutations in West syndrome and intellectual disability with focal epilepsy.
    Lemke JR; Hendrickx R; Geider K; Laube B; Schwake M; Harvey RJ; James VM; Pepler A; Steiner I; Hörtnagel K; Neidhardt J; Ruf S; Wolff M; Bartholdi D; Caraballo R; Platzer K; Suls A; De Jonghe P; Biskup S; Weckhuysen S
    Ann Neurol; 2014 Jan; 75(1):147-54. PubMed ID: 24272827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Positive allosteric modulators that target NMDA receptors rectify loss-of-function GRIN variants associated with neurological and neuropsychiatric disorders.
    Tang W; Liu D; Traynelis SF; Yuan H
    Neuropharmacology; 2020 Oct; 177():108247. PubMed ID: 32712275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. De novo GABRA1 mutations in Ohtahara and West syndromes.
    Kodera H; Ohba C; Kato M; Maeda T; Araki K; Tajima D; Matsuo M; Hino-Fukuyo N; Kohashi K; Ishiyama A; Takeshita S; Motoi H; Kitamura T; Kikuchi A; Tsurusaki Y; Nakashima M; Miyake N; Sasaki M; Kure S; Haginoya K; Saitsu H; Matsumoto N
    Epilepsia; 2016 Apr; 57(4):566-73. PubMed ID: 26918889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GRIN1 mutations cause encephalopathy with infantile-onset epilepsy, and hyperkinetic and stereotyped movement disorders.
    Ohba C; Shiina M; Tohyama J; Haginoya K; Lerman-Sagie T; Okamoto N; Blumkin L; Lev D; Mukaida S; Nozaki F; Uematsu M; Onuma A; Kodera H; Nakashima M; Tsurusaki Y; Miyake N; Tanaka F; Kato M; Ogata K; Saitsu H; Matsumoto N
    Epilepsia; 2015 Jun; 56(6):841-8. PubMed ID: 25864721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional Properties of Human NMDA Receptors Associated with Epilepsy-Related Mutations of GluN2A Subunit.
    Sibarov DA; Bruneau N; Antonov SM; Szepetowski P; Burnashev N; Giniatullin R
    Front Cell Neurosci; 2017; 11():155. PubMed ID: 28611597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epilepsy-associated GRIN2A mutations reduce NMDA receptor trafficking and agonist potency - molecular profiling and functional rescue.
    Addis L; Virdee JK; Vidler LR; Collier DA; Pal DK; Ursu D
    Sci Rep; 2017 Feb; 7(1):66. PubMed ID: 28242877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A
    Ishii A; Kang JQ; Schornak CC; Hernandez CC; Shen W; Watkins JC; Macdonald RL; Hirose S
    J Med Genet; 2017 Mar; 54(3):202-211. PubMed ID: 27789573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Palmitoylation Controls NMDA Receptor Function and Steroid Sensitivity.
    Hubalkova P; Ladislav M; Vyklicky V; Smejkalova T; Hrcka Krausova B; Kysilov B; Krusek J; Naimová Z; Korinek M; Chodounska H; Kudova E; Cerny J; Vyklicky L
    J Neurosci; 2021 Mar; 41(10):2119-2134. PubMed ID: 33526476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenotypic spectrum of GNAO1 variants: epileptic encephalopathy to involuntary movements with severe developmental delay.
    Saitsu H; Fukai R; Ben-Zeev B; Sakai Y; Mimaki M; Okamoto N; Suzuki Y; Monden Y; Saito H; Tziperman B; Torio M; Akamine S; Takahashi N; Osaka H; Yamagata T; Nakamura K; Tsurusaki Y; Nakashima M; Miyake N; Shiina M; Ogata K; Matsumoto N
    Eur J Hum Genet; 2016 Jan; 24(1):129-34. PubMed ID: 25966631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High prevalence of genetic alterations in early-onset epileptic encephalopathies associated with infantile movement disorders.
    Kobayashi Y; Tohyama J; Kato M; Akasaka N; Magara S; Kawashima H; Ohashi T; Shiraishi H; Nakashima M; Saitsu H; Matsumoto N
    Brain Dev; 2016 Mar; 38(3):285-92. PubMed ID: 26482601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms for Zinc and Proton Inhibition of the GluN1/GluN2A NMDA Receptor.
    Jalali-Yazdi F; Chowdhury S; Yoshioka C; Gouaux E
    Cell; 2018 Nov; 175(6):1520-1532.e15. PubMed ID: 30500536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spectrum of NMDA Receptor Variants in Neurodevelopmental Disorders and Epilepsy.
    Gjerulfsen CE; Krey I; Klöckner C; Rubboli G; Lemke JR; Møller RS
    Methods Mol Biol; 2024; 2799():1-11. PubMed ID: 38727899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations in SCN3A cause early infantile epileptic encephalopathy.
    Zaman T; Helbig I; Božović IB; DeBrosse SD; Bergqvist AC; Wallis K; Medne L; Maver A; Peterlin B; Helbig KL; Zhang X; Goldberg EM
    Ann Neurol; 2018 Apr; 83(4):703-717. PubMed ID: 29466837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. De novo mutations of voltage-gated sodium channel alphaII gene SCN2A in intractable epilepsies.
    Ogiwara I; Ito K; Sawaishi Y; Osaka H; Mazaki E; Inoue I; Montal M; Hashikawa T; Shike T; Fujiwara T; Inoue Y; Kaneda M; Yamakawa K
    Neurology; 2009 Sep; 73(13):1046-53. PubMed ID: 19786696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole-exome sequencing in an individual with severe global developmental delay and intractable epilepsy identifies a novel, de novo GRIN2A mutation.
    Venkateswaran S; Myers KA; Smith AC; Beaulieu CL; Schwartzentruber JA; ; Majewski J; Bulman D; Boycott KM; Dyment DA
    Epilepsia; 2014 Jul; 55(7):e75-9. PubMed ID: 24903190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.